血液静止剂粉末的疗效用于内镜治疗恶性上部胃肠道出血
J P Pérez-Macías1, M E Ramírez-Solís1, A I Hernández-Guerrero1
1Departamento de Endoscopia Gastrointestinal, Instituto Nacional de Cancerología, Tlalpan, Mexico City, Mexico.
Revista de gastroenterologia de Mexico (English)
|June 10, 2025
概括
静血粉可以实现100%的初始控制癌症上部胃肠道出血. 然而,再出血是常见的,使得粉末在最终治疗之前成为临时溶液.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 内镜血液静止症 (Endoscopic Hemostasis) 是一种内镜血液静止症.
背景情况:
- 癌症引起的上胃肠道出血 (UGIB) 是罕见但严重的.
- 标准的内镜治疗面临的挑战是分散的排泄和再出血.
- 静血粉为这些困难病例提供了潜在的治疗选择.
研究的目的:
- 为了评估血静粉末的初始血静率.
- 为了评估治疗后7天和30天的再出血率.
- 分析患有恶性UGIB的患者的结局.
主要方法:
- 追溯观察性研究 (2018-2023年).
- 对人口,临床和内镜数据的分析.
- 血液静止粉末的疗效和再出血率的评估.
主要成果:
- 包括54名患有恶性UGIB的患者;40.7%患有胃癌.
- 静血粉 (EndoClotTM) 实现了100%的初始静血.
- 7天复出率为22.2%,30天复出率为44.4%,30天死亡率为35.2%.
结论:
- 静血粉是有效的立即控制出血在恶性UGIB.
- 静血效应是暂时的,建议用作桥梁疗法.
- 促进后续最终治疗的稳定.
关键词:
血液静止剂 (Agente hemostático) 是一种血液静止剂.癌症 癌症 癌症 癌症癌症 癌症 癌症这就是EndoClotTM.内镜治疗治疗的目的是.胃肠道出血 胃肠道出血胃肠道出血 胃肠道出血静血剂是一种静血剂.这是一种内镜疗法 (endoscopic therapy).更多相关视频
相关概念视频
Esophageal Varices-II: Clinical Features and Management
48
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
48
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
409
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
409
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3


